Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemma. [PDF]
Amamoo RS +5 more
europepmc +1 more source
A review of treatment strategies for elderly patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia. [PDF]
Shi K, Wang G, Sun X.
europepmc +1 more source
Enhancing tyrosine kinase inhibitor sensitivity by restoring IKAROS activity on GLUT1 expression and glycolysis in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Zhang L +10 more
europepmc +1 more source
Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report. [PDF]
Kawai H +5 more
europepmc +1 more source
Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review. [PDF]
Yang L, Huang M, Chen Y, Wu Y.
europepmc +1 more source
Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway. [PDF]
Ren Q, Li X, Ye X, Feng L.
europepmc +1 more source
Long-term outcomes of co-administration of CD19 and CD22 CAR-T cell therapy in pediatric patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Zhou Z +19 more
europepmc +1 more source
Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study. [PDF]
Li Y +10 more
europepmc +1 more source
An autopsy case of bullous retinal detachment and hypopyon in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]
Takenaka M +8 more
europepmc +1 more source
Deletion mutations of the <i>ABL1</i> gene in Philadelphia chromosome-positive acute lymphoblastic leukemia: high prevalence with limited clinical impact. [PDF]
Takano H +15 more
europepmc +1 more source

